Thank you for Subscribing to CIO Applications Weekly Brief

Prognos Marketplace Now Offers Arcadia Research Data
Organizations can offer better care and quality to patients with EHRs and their ability to share electronic information.
By
CIO Applications | Friday, August 19, 2022

An electronic health record data source is available on the platform to provide life science organizations with deeper clinical insights for optimizing their therapies.
FREMONT, CA: Organizations can offer better care and quality to patients with EHRs and their ability to share electronic information. Doctors can check a patient's health status and monitor its treatment under the supervision and guidance of other doctors. A patient's medical history can significantly enhance internal communication among staff, thanks to an EHR. Arcadia is one of the premier data analytics platforms for healthcare, and life sciences, revealed that it is now available on Prognos Marketplace. Prognos is addressing the problem of isolated, segregated data that cannot interoperate, resulting in an incomplete picture of the patient, such as test results, prescription information, and medical claims.
"We are pleased to democratize access to health data at scale by joining Prognos' data partner ecosystem. The clinical information available in our EHR data will enable these organizations to gather deeper, more accurate medical assessments that can accelerate the advancement of new, life-saving therapies to millions of patients." says Jim Robbins, SVP of Life Sciences at Arcadia.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Arcadia is the platform's initial source of electronic health record (EHR) data, giving clinical insights that will allow Prognos' life science customers to improve and speed therapeutic strategies.
Arcadia Research Data provides:
• Live EHRs and claims-based patient population data.
• Providing complete insight across payers.
• Numerous places of treatment.
• The whole clinical patient experience.
Prognos Marketplace allows linkage and access to Arcadia's de-identified RWD data to produce insights for life sciences research to enhance health/patient outcomes.
"Prognos' life science customers can now include Arcadia's data in their cohort searches and purchase record-level data to inform therapy targeting, map the patient journey, and support therapy launch and commercialization efforts. Providing the ability to combine patients' data across all data types including lab, claims, pharmacy, EHR, mortality, and SDoH data is critical to improving patient outcomes." says Sundeep Bhan, CEO at Prognos Health.
More in News

